Trial Profile
A prospective study of rivaroxaban in the prevention of PICC related thrombosis in cancer patients
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 11 Apr 2017
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Venous thromboembolism
- Focus Therapeutic Use
- 11 Apr 2017 New trial record